Dermatology Excimer Laser Market Size & Growth Forecast 2027–2036, By Segments (Product, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Dermatology Excimer Laser Market size was valued at USD 777.9 Million in 2026 and is anticipated to grow at a 9.79% CAGR from 2027 to 2036, surpassing USD 1.98 billion by 2036. The industry revenue for 2027 is calculated at USD 842 Million.
Get more details on this report
Request Free Sample ReportDermatology Excimer Laser Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 40.49% market share in 2026, supported by established dermatology infrastructure, specialist clinics, and consistent use of excimer laser treatments for chronic skin conditions.
- Asia Pacific is forecast to grow at an 11.42% CAGR as expanding dermatology services, greater laser device availability, and rising patient awareness increase adoption across hospitals and specialty clinics.
Segment Momentum
- Dermatology clinics led the market in 2026 because they remain the primary setting for diagnosing and routinely treating skin conditions requiring excimer laser therapy, supported by specialist expertise and consistent patient volumes.
- Hand-held excimer lasers are growing rapidly because they offer greater portability, flexible deployment, and suitability for smaller practices, supporting expanding outpatient treatment and more space-efficient clinical workflows.
Market Expansion Drivers
- Rising prevalence of psoriasis and vitiligo driving demand for targeted laser dermatology treatments.
- Growing preference for non-invasive cosmetic and dermatology procedures accelerating laser adoption.
- Integration of AI-enabled treatment planning improving precision and personalized dermatology care.
Leading Market Participants
- Top players in the dermatology excimer laser market include Ra Medical Systems, Inc. (United States), Lumenis Ltd. (Israel), Hologic, Inc. (United States), Fotona d.o.o. (Slovenia), Alma Lasers (Israel), Strata Skin Sciences, Inc. (United States), DEKA Research & Development Corp. (Italy), Beijing Sincoheren S&T Development Co., Ltd (China), Shenzhen GSD Tech Co., Ltd. (China), The Daavlin Company (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 777.9 Million
- 2027 Estimated Market Size: USD 842 Million.
- Projected Market Size: USD 1.98 billion by 2036
- Growth Forecast: 9.79% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Trolley Mounted Excimer Lasers (Product) | Dermatology Clinics (End-use) | Psoriasis (Application)
- Emerging Opportunity Segment: Hand-held Excimer Lasers (Product) | Plastic Surgery Centers (End-use) | Vitiligo (Application)
Market Growth Drivers and Industry Trends
Rising prevalence of psoriasis and vitiligo driving demand for targeted laser dermatology treatments
The rising prevalence of psoriasis and vitiligo is strengthening demand in the dermatology excimer laser market by increasing the need for focused therapies that can address localized skin lesions while limiting exposure to unaffected areas. Excimer laser systems deliver concentrated ultraviolet light directly to affected skin, making them suitable for patients requiring targeted management of depigmented or inflamed lesions. Growing clinical awareness of disease-specific treatment options is also encouraging dermatology practices to incorporate laser-based interventions alongside conventional topical and systemic therapies, particularly where localized treatment and controlled energy delivery are clinically desirable.
Growing preference for non-invasive cosmetic and dermatology procedures accelerating laser adoption
Growing patient preference for non-invasive and minimally disruptive procedures is supporting the dermatology excimer laser market as consumers increasingly seek treatments that can be performed without surgical intervention and with limited disruption to daily activities. Excimer laser procedures offer controlled treatment delivery without incisions, making them attractive for selected dermatological and cosmetic applications where precision is important. The broader shift toward outpatient aesthetic and dermatology care is also encouraging clinics to invest in laser platforms that can support procedure-based treatment while improving patient convenience and reducing the need for more invasive approaches.
Integration of AI-enabled treatment planning improving precision and personalized dermatology care
Integration of AI-enabled treatment planning is creating new opportunities for the dermatology excimer laser market by supporting more precise assessment of skin conditions and treatment parameters. AI-based systems can assist clinicians in evaluating lesion characteristics, identifying treatment areas, and developing more individualized therapy protocols, which can improve consistency in energy delivery and treatment targeting. The combination of intelligent software with laser systems can also help dermatologists manage patient-specific variations in disease presentation and treatment response, strengthening the role of technology-assisted care in specialized dermatology practices.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of psoriasis and vitiligo driving demand for targeted laser dermatology treatments | 2.00% | High | North America, Europe | High | Near Term |
| Growing preference for non-invasive cosmetic and dermatology procedures accelerating laser adoption | 1.80% | Moderate | North America, Asia Pacific | High | Near Term |
| Integration of AI-enabled treatment planning improving precision and personalized dermatology care | 1.50% | High | Europe, North America | Emerging | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America held the largest share of the dermatology excimer laser market at 40.49% in 2026, supported by advanced dermatological care infrastructure, strong demand for targeted light-based treatments, and broad adoption of specialized technologies for chronic skin conditions. The region’s established healthcare ecosystem, emphasis on minimally invasive procedures, and continued investment in sophisticated dermatology equipment reinforce its market position. Increasing patient awareness and preference for precise, outpatient treatment options further support the adoption of excimer laser systems across clinical settings.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market, driven by expanding healthcare infrastructure, rising dermatology awareness, and improving access to advanced aesthetic and therapeutic procedures. Growing healthcare expenditure, increasing demand for specialized skin treatments, and greater availability of modern medical technologies are encouraging broader adoption across hospitals, dermatology clinics, and specialty centers. The region’s expanding patient base and growing focus on advanced dermatological solutions are expected to strengthen its growth trajectory.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Specialist Clinic UtilizationGermany is emphasizing dermatology excimer laser technologies within specialized clinics focused on chronic skin disease management. The market in Germany is seeing steady adoption of laser systems that offer localized treatment while minimizing exposure to surrounding healthy tissue.
France 🇫🇷
Chronic Disease Management ToolsFrance is utilizing dermatology excimer lasers as part of comprehensive treatment strategies for persistent skin disorders. The French market is prioritizing technologies that provide targeted intervention options and support individualized patient treatment pathways.
Italy 🇮🇹
Outpatient Treatment EfficiencyItaly is adopting dermatology excimer laser systems that enable efficient outpatient management of psoriasis and vitiligo. Dermatology centers in Italy are focusing on equipment that improves treatment precision and expands noninvasive therapeutic options for patients.
Japan 🇯🇵
Precision Skin TherapiesJapan is increasingly adopting dermatology excimer lasers for targeted treatment approaches that address complex skin conditions. Healthcare providers in Japan value technologies that provide effective therapy with reduced treatment areas and improved patient comfort.
South Korea 🇰🇷
Aesthetic Dermatology ExpansionSouth Korea's strong dermatology sector is supporting broader adoption of excimer laser systems for therapeutic and specialized skin applications. Clinics in South Korea are investing in advanced laser technologies that complement the country's sophisticated dermatological care infrastructure.
United States 🇺🇸
Advanced Dermatology ProceduresThe U.S. dermatology excimer laser market is driven by strong demand for targeted treatments of psoriasis, vitiligo, and other chronic skin disorders. Dermatology clinics in the U.S. are investing in advanced laser platforms that improve treatment precision and patient outcomes.
Segment Leadership and Growth Trends
Dermatology Excimer Laser Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Trolley Mounted Excimer Lasers (Largest Segment) vs Hand-held Excimer Lasers (Fastest-Growing Segment)
Trolley mounted excimer lasers accounted for the largest share of the dermatology excimer laser market in 2026, representing 46.22% of the market, supported by their established use in dermatological procedures requiring controlled laser delivery and consistent treatment performance. Their suitability for clinical environments with dedicated treatment areas, combined with established physician familiarity and integration into dermatology workflows, supports continued utilization. Growing demand for targeted laser-based treatment and increasing attention to procedural precision are further reinforcing the segment's position.
Hand-held excimer lasers are witnessing the fastest growth as dermatology providers increasingly value portability, treatment flexibility, and convenient device handling. Compact laser systems can support easier movement between treatment areas and greater adaptability for procedures requiring targeted application. The broader shift toward efficient outpatient care and demand for flexible dermatological treatment technologies are creating favorable conditions for increased adoption of hand-held systems.
End-use Segment Analysis: Dermatology Clinics (Largest Segment) vs Plastic Surgery Centers (Fastest-Growing Segment)
Dermatology clinics held the largest share of the dermatology excimer laser market in 2026, reflecting their specialized focus on skin disorders and their established infrastructure for laser-based dermatological procedures. These clinics provide dedicated expertise and treatment environments suited to excimer laser applications, supporting consistent utilization across a range of skin-related conditions. Increasing demand for specialized dermatological care and growing preference for targeted, non-invasive or minimally invasive treatment approaches are sustaining the segment's market presence.
Plastic surgery centers represent the fastest-growing end-use segment as these facilities increasingly incorporate advanced energy-based technologies into broader aesthetic and skin-treatment offerings. Excimer lasers can complement specialized treatment portfolios by enabling targeted dermatological procedures within centers focused on appearance and skin health. Rising consumer interest in advanced skin treatments and the expansion of technology-enabled aesthetic care are supporting greater adoption in plastic surgery settings.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Table Top Excimer Lasers, Hand-held Excimer Lasers, Trolley Mounted Excimer Lasers | Trolley Mounted Excimer Lasers | Hand-held Excimer Lasers |
| End-use | Hospitals, Dermatology Clinics, Plastic Surgery Centers | Dermatology Clinics | Plastic Surgery Centers |
| Application | Psoriasis, Vitiligo, Atopic Dermatitis, Allergic Rhinitis, Alopecia Areata, Others | Psoriasis | Vitiligo |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Major players in the dermatology excimer laser market:
1. Ra Medical Systems Inc. (United States)
2. Lumenis Ltd. (Israel)
3. Hologic Inc. (United States)
4. Fotona d.o.o. (Slovenia)
5. Alma Lasers (Israel)
6. Strata Skin Sciences Inc. (United States)
7. DEKA Research & Development Corp. (Italy)
8. Beijing Sincoheren S&T Development Co. Ltd (China)
9. Shenzhen GSD Tech Co. Ltd. (China)
10. The Daavlin Company (United States)
The dermatology excimer laser market is experiencing strong innovation focused on precision-based skin treatment solutions. In the dermatology excimer laser market, technological upgrades are improving treatment accuracy and reducing recovery time. New laser systems are being introduced with enhanced safety and performance features. Continuous research is enabling more effective management of chronic dermatological conditions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Ra Medical Systems Inc. (United States) | |||||||
| Lumenis Ltd. (Israel) | |||||||
| Hologic Inc. (United States) | |||||||
| Fotona d.o.o. (Slovenia) | |||||||
| Alma Lasers (Israel) | |||||||
| Strata Skin Sciences Inc. (United States) | |||||||
| DEKA Research & Development Corp. (Italy) | |||||||
| Beijing Sincoheren S&T Development Co. Ltd (China) | |||||||
| Shenzhen GSD Tech Co. Ltd. (China) | |||||||
| The Daavlin Company (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Alma Lasers | 2025 | Alma Lasers introduced AI-assisted dermatology laser technologies, enhancing precision and treatment optimization in dermatological procedures. The development strengthens its portfolio in advanced laser-based skin treatment systems and supports broader integration of intelligent technologies in dermatology care workflows. |
| Ra Medical Systems, Inc. | 2025 | Ra Medical Systems expanded research into portable excimer laser technologies for outpatient dermatology clinics, focusing on improving accessibility and mobility of laser-based skin treatments. The initiative supports development of compact systems tailored for decentralized dermatology care settings. |
| STRATA Skin Sciences Inc. | Jul-24 | STRATA Skin Sciences received regulatory approval from Japan’s Ministry of Health, Labour and Welfare for its XTRAC Momentum 1.0 excimer laser device. The approval enables commercialization in Japan through its partner JMEC Co. Ltd., strengthening STRATA’s regional presence and expanding access to excimer laser-based treatments for dermatological conditions including psoriasis and vitiligo. |
| STRATA Skin Sciences, Inc. | Jul-24 | STRATA Skin Sciences expanded commercialization of targeted phototherapy systems for psoriasis treatment programs, supporting broader clinical adoption of its dermatology laser technologies. The initiative reinforces the company’s positioning in excimer-based dermatology treatments and enhances its installed base across clinical settings. |
| Fotona d.o.o. | 2024 | Fotona launched enhanced precision phototherapy platforms for vitiligo treatment, expanding its dermatology laser technology offerings. The development reinforces its focus on precision-based skin therapy solutions and strengthens its position in excimer and phototherapy-based dermatology treatment systems. |
| Lumenis, Ltd. | 2023 | Lumenis increased investment in compact dermatology excimer laser systems, focusing on portable and space-efficient treatment solutions. This strategic emphasis supports broader adoption in clinical dermatology settings and strengthens its competitive positioning in minimally invasive laser therapy systems. |
| STRATA Skin Sciences, Inc. | Aug-21 | STRATA Skin Sciences acquired the U.S. dermatology division of Ra Medical Systems, including the PHAROS excimer laser system. The acquisition expands STRATA’s excimer laser therapy portfolio and strengthens its position in dermatology treatment systems by integrating additional laser-based therapeutic capabilities. |
| LASEROPTEK Co. Ltd. | Aug-20 | LASEROPTEK launched its PALLAS Solid-State 311nm UVB laser in the U.S., cleared by the FDA for treatment of vitiligo, psoriasis, atopic dermatitis, and leukoderma. The solid-state design eliminates gas and electrodes, improving operational efficiency and strengthening LASEROPTEK’s competitive position in dermatology laser systems. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Dermatology Excimer Laser Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Treatment Objective | Medical Dermatology, Cosmetic Dermatology, Combination Medical-Cosmetic Treatment |
| Patient Age Group | Pediatric, Adult, Geriatric |
| Procurement Model | Direct Purchase, Equipment Leasing, Equipment Financing, Pay-Per-Use |
Dermatology Excimer Laser Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Clinical Application Expansion Assessment |
|
| Dermatology Treatment Adoption Barriers |
|
| Aesthetic Medicine Opportunity Mapping |
|
Need a different cut of the data?
Request Custom ResearchHow large is the dermatology excimer laser market?
How is the dermatology excimer laser industry projected to perform over the next decade?
How are changing patient preferences influencing adoption of excimer laser treatments?
How is AI-enabled treatment planning shaping the future of dermatology laser adoption?
Which end-use segment holds the largest share of the dermatology excimer laser market?
Why are hand-held excimer lasers the fastest-growing product segment?
Why is North America the leading regional market for dermatology excimer lasers?
What is fueling the growth of the dermatology excimer laser market in Asia Pacific?
Who holds a significant market share in the dermatology excimer laser landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization